Conservest Capital Advisors Inc. Lowers Holdings in SPDR S&P Biotech ETF (NYSEARCA:XBI)

Conservest Capital Advisors Inc. cut its position in SPDR S&P Biotech ETF (NYSEARCA:XBI) by 21.2% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 32,163 shares of the exchange traded fund’s stock after selling 8,650 shares during the quarter. Conservest Capital Advisors Inc.’s holdings in SPDR S&P Biotech ETF were worth $2,897,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other institutional investors and hedge funds have also bought and sold shares of XBI. Howard Capital Management Group LLC lifted its stake in SPDR S&P Biotech ETF by 2.6% in the 3rd quarter. Howard Capital Management Group LLC now owns 248,114 shares of the exchange traded fund’s stock worth $24,514,000 after purchasing an additional 6,188 shares in the last quarter. Financial Advocates Investment Management purchased a new stake in SPDR S&P Biotech ETF in the 3rd quarter worth approximately $1,300,000. Focus Financial Network Inc. purchased a new stake in shares of SPDR S&P Biotech ETF during the 3rd quarter valued at $218,000. Pursue Wealth Partners LLC raised its position in shares of SPDR S&P Biotech ETF by 9.0% during the 3rd quarter. Pursue Wealth Partners LLC now owns 14,804 shares of the exchange traded fund’s stock valued at $1,463,000 after buying an additional 1,227 shares in the last quarter. Finally, Shepherd Financial Partners LLC raised its position in shares of SPDR S&P Biotech ETF by 14.2% during the 3rd quarter. Shepherd Financial Partners LLC now owns 10,450 shares of the exchange traded fund’s stock valued at $1,032,000 after buying an additional 1,298 shares in the last quarter.

SPDR S&P Biotech ETF Stock Performance

SPDR S&P Biotech ETF stock opened at $88.71 on Friday. The firm’s fifty day moving average price is $91.00 and its 200-day moving average price is $95.76. The stock has a market cap of $5.85 billion, a P/E ratio of 11.47 and a beta of 0.93. SPDR S&P Biotech ETF has a fifty-two week low of $81.14 and a fifty-two week high of $105.47.

About SPDR S&P Biotech ETF

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.